State of Alaska Department of Revenue increased its stake in Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating) by 9.4% during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 28,832 shares of the company's stock after buying an additional 2,480 shares during the period. State of Alaska Department of Revenue owned 0.05% of Apollo Medical worth $1,112,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in AMEH. Lazard Asset Management LLC bought a new position in Apollo Medical in the 1st quarter valued at approximately $66,000. PNC Financial Services Group Inc. lifted its position in Apollo Medical by 49.9% in the 1st quarter. PNC Financial Services Group Inc. now owns 1,563 shares of the company's stock valued at $75,000 after acquiring an additional 520 shares in the last quarter. Mutual of America Capital Management LLC lifted its position in Apollo Medical by 5.5% in the 1st quarter. Mutual of America Capital Management LLC now owns 5,442 shares of the company's stock valued at $264,000 after acquiring an additional 282 shares in the last quarter. Jupiter Asset Management Ltd. bought a new position in Apollo Medical in the 1st quarter valued at approximately $266,000. Finally, GSA Capital Partners LLP bought a new position in Apollo Medical in the 1st quarter valued at approximately $331,000. Hedge funds and other institutional investors own 32.03% of the company's stock.
Get Apollo Medical alerts:Apollo Medical Trading Down 2.8 %
Shares of NASDAQ:AMEH opened at $39.39 on Wednesday. Apollo Medical Holdings, Inc. has a 52-week low of $29.52 and a 52-week high of $133.23. The stock has a market capitalization of $2.22 billion, a price-to-earnings ratio of 24.62 and a beta of 0.75. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.49 and a current ratio of 2.49. The stock's 50-day simple moving average is $46.38 and its two-hundred day simple moving average is $42.46.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the company. Barclays upped their price objective on Apollo Medical from $50.00 to $57.00 and gave the company an "equal weight" rating in a research report on Monday, August 8th. William Blair started coverage on Apollo Medical in a research report on Wednesday, September 21st. They issued an "outperform" rating on the stock.About Apollo Medical
(Get Rating)
Apollo Medical Holdings, Inc, a physician-centric technology-powered healthcare company, provides medical care services. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Recommended Stories
- Get a free copy of the StockNews.com research report on Apollo Medical (AMEH)
- Defensive Stocks For A Volatile Market
- Will UPS Be Next to Deliver a Warning?
- SunPower Is Ready To Power Up Triple-Digit Earnings Gains
- Is This the Darkest Before the Dawn for Gap Stock?
- Build A Better Tech Portfolio With Jabil Inc.
Want to see what other hedge funds are holding AMEH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Apollo Medical Holdings, Inc. (NASDAQ:AMEH – Get Rating).
Receive News & Ratings for Apollo Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apollo Medical and related companies with MarketBeat.com's FREE daily email newsletter.